Pharmaceutical Machineries: Global Market
The pharmaceutical machineries made by India are installed and under operations at all the FDA Approved manufacturing facilities in USA, Australia, Africa, etc. meeting the parameters of complete satisfactions. The high credentials goes to strict quality standards adopted by the pharmaceutical machinery manufacturers in India, which had lead some of the Indian companies have entered in to the technical tie-ups / joint ventures with USA, Europe and South East Asian companies to manufacture their products in India and being marketed in all Asian and CIS counties. Emerging markets such as China, Russia, Turkey and Korea had double digit growth, contributing significantly to this large growth rate.
In the next five years, world pharmaceutical market alone is poised grow at a rate of 8 percent with business opportunity of over a US$ trillion. Countries like USA, Japan and those of Europe led by Germany shall remain dominant market controlling over 80 percent trade opportunities. Asian countries like South Korea, Taiwan and India are expected to have growth rates ranging from 12 to 15 percent annually.
The new product patent regime and increased proportion of Indian pharmaceutical exports to advanced markets is gearing Indian pharma machinery manufacturers to better GMP and higher technological adaptation. Indian machinery companies have started to follow proper documentation and maintenance of records for every manufacturing and maintenance procedure, which is demanded by international buyers. Indian machinery manufacturers are perfectly evolving with changing times. Today, Indian machines are far better in quality and in par with international standards, than it used to be 15 years ago. Indian manufacturers follow the ISO 14000 and 9001 series of quality certification. Due to industry trends such as off-shoring and outsourcing, there are an increasing number of pharmaceutical manufacturers in Asia, and instrument providers are keen to take advantage of this booming market.
North America remains the largest Pharmaceutical market constituting 49% of the worldwide market followed by Europe and Asia-Pacific. Pharmaceutical market across the world is witnessing increased opportunities in the area of Bio Pharmaceuticals, Pharmacogenomics and Biologics market. The smaller national markets in Asia-Pacific and Latin America are expected to grow significantly and will increase their presence in the global Pharmaceutical landscape.
The top big players now are concentrating on the regulated US and European markets, giving their local giants a run for their money. It is common knowledge that USA and Europe take up the lion's share of around 80% of the global pharma market. The model keeps on upgrading the total culture of the industry and encouraging the medium companies to enter the export market. The entry of the top companies in the regulated markets and their success in the generic market has become benchmark for all the small & mid-size companies. The phenomenal growth of these companies & growing profit margins means a bonanza for their stockholders, fuelling fresh investment in the Industry.
In terms of pharmaceutical packaging, there is robust growth ahead for this sector. The global pharmaceutical and healthcare packaging market will grow with a compound annual growth rate (CAGR) of 6.2 % in 2009. With approximately 34 % of the share, North America is still the largest market, followed by Western Europe with 29 % and Asia with 24 %. Eastern Europe's share is relatively low at 4.5 % but expected to increase above average to 5.3 % in 2009. The pharmaceutical packaging technology market is estimated to grow by 4.3 % until 2009.
The U.S. pharmaceutical industry has achieved worldwide prominence through research and development (R&D) work on new drugs, and spends a relatively high proportion of its funds on R&D compared with other industries.
India: The Market Place
Indian pharmaceutical industry is not only one of the fastest growing sectors of Indian economy but also a leading player in the world - ranking 4th in volume and 13th in value terms. With an annual turnover of Rs 1,500 crore and growing at over 10% per annum Indian pharmaceutical machinery manufacturing sector constitutes around 5% of the global market in value terms. The rise in joint ventures between foreign and Indian pharma companies proves that India can make world-class products at affordable prices. There are also significant opportunities for pharmaceutical plant design consultancy and related services especially for large companies adapting to USFDA, UKMCC standards. Overall, being the lowest cost producer combined with FDA approved plants, India promises to be a global outsourcing hub for pharmaceutical products.
Figures on Pharmaceutical Machinery
- Rs 1,500 crores - Estimated market
- 10% - Rate of growth
- 400 - Organised machinery makers
- Rs 200 crores - Export of machines/year
- 5% - Annual import